journal article·2019-02

Light‐Inducible Exosome‐Based Vehicle for Endogenous RNA Loading and Delivery to Leukemia Cells

Lin Huang, Ning Gu, Xian‐En Zhang, Dian‐Bing Wang

Advanced Functional Materials· Volume 29· Issue 9
Publisher page

Abstract

Abstract Exosomes are a novel and promising drug delivery platform because of their endogenous origin, stability, biocompatibility, and other unique features. As the efficient loading and delivery of long RNA to target cells for therapeutic purposes remains challenging, a new exosome‐based RNA delivery system is proposed using a controllable RNA enrichment and releasing protocol. The system employs RNA aptamer–protein interactions and reversible light‐inducible protein–protein interaction modules by remolding exosome producer cells. Endogenous microRNA 21 (miR‐21) sponges, inhibitors of miR‐21, are successfully enriched on the plasma membrane and are sorted into exosomes by the biogenesis of the exosomes. The loading capacity of miR‐21 sponges is enhanced by 14‐fold in the light‐inducible loading system. In addition, targeted delivery of miR‐21 to leukemia cells is achieved by modifying exosomes with the cholesterol‐conjugated aptamer AS1411, resulting in significant cell apoptosis by blocking the function of miR‐21 in leukemia cells. This work provides an exosome‐based light‐inducible vehicle to efficiently load and deliver long endogenous RNA, which can enable more RNA‐based therapeutics for personalized cancer medicine.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA Interference and Gene Delivery · Extracellular vesicles in disease · MicroRNA in disease regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

School of Biological Science and Medical Engineering Southeast University Nanjing 210096 P. R. China

National Laboratory of Biomacromolecules CAS Center for Excellence in Biomacromolecules Institute of Biophysics Chinese Academy of Sciences Beijing 100101 China

Funding

Chinese Academy of Sciences

References (36)

Show source-provided references
1. 10.1038/nbt.380210.1038/nbt.3802 ↗
2. 10.1038/nrd414010.1038/nrd4140 ↗
3. 10.1038/nature0928410.1038/nature09284 ↗
4. 10.1182/blood-2008-06-16598510.1182/blood-2008-06-165985 ↗
5. 10.1186/2047-783X-15-4-15210.1186/2047-783X-15-4-152 ↗
6. 10.1073/pnas.040443210110.1073/pnas.0404432101 ↗
7. 10.1038/nmeth107910.1038/nmeth1079 ↗
8. 10.1016/j.cell.2009.03.04710.1016/j.cell.2009.03.047 ↗
9. 10.1016/j.addr.2014.05.01010.1016/j.addr.2014.05.010 ↗
10. 10.1038/nbt.161810.1038/nbt.1618 ↗
11. 10.1038/ncomms1098210.1038/ncomms10982 ↗
12. 10.1186/s13073-017-0450-010.1186/s13073-017-0450-0 ↗
13. 10.1038/nrd.2016.24610.1038/nrd.2016.246 ↗
14. 10.1016/j.addr.2014.05.00910.1016/j.addr.2014.05.009 ↗
15. 10.1016/S0021-9258(18)48095-710.1016/S0021-9258(18)48095-7 ↗
16. 10.1038/nri85510.1038/nri855 ↗
17. 10.1016/j.cell.2015.04.04210.1016/j.cell.2015.04.042 ↗
18. 10.1038/ncb159610.1038/ncb1596 ↗
19. 10.1038/ncomms1358010.1038/ncomms13580 ↗
20. 10.1002/adma.20170535010.1002/adma.201705350 ↗
21. 10.7150/thno.1709210.7150/thno.17092 ↗
22. 10.1016/j.biomaterials.2017.07.01110.1016/j.biomaterials.2017.07.011 ↗
23. 10.1038/nature2234110.1038/nature22341 ↗
24. 10.1038/s41467-018-03733-810.1038/s41467-018-03733-8 ↗
25. 10.1016/j.jconrel.2011.11.02110.1016/j.jconrel.2011.11.021 ↗
26. 10.1146/annurev-pharmtox-010814-12463010.1146/annurev-pharmtox-010814-124630 ↗
27. 10.1016/j.addr.2012.08.00810.1016/j.addr.2012.08.008 ↗
28. 10.1080/20013078.2017.133388210.1080/20013078.2017.1333882 ↗
29. 10.1016/j.jconrel.2013.08.01410.1016/j.jconrel.2013.08.014 ↗
30. 10.4161/rna.8.5.1615410.4161/rna.8.5.16154 ↗
31. 10.1038/nmeth.152410.1038/nmeth.1524 ↗
32. 10.1038/ncomms802910.1038/ncomms8029 ↗
33. 10.1182/blood-2006-08-04325710.1182/blood-2006-08-043257 ↗
34. 10.1016/j.ceb.2014.05.00410.1016/j.ceb.2014.05.004 ↗
35. 10.4161/cbt.10.12.1425210.4161/cbt.10.12.14252 ↗
36. 10.1111/j.1349-7006.2010.01489.x10.1111/j.1349-7006.2010.01489.x ↗